Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
Contemporary ventricular assist device therapy results in a high rate of successful heart transplantation but is associated with bleeding, infections, and other complications. Further reductions in pump size, centrifugal design, and intrapericardial positioning may reduce complications and improve o...
Gespeichert in:
| Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2012-06, Vol.125 (25), p.3191-3200 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3200 |
|---|---|
| container_issue | 25 |
| container_start_page | 3191 |
| container_title | Circulation (New York, N.Y.) |
| container_volume | 125 |
| creator | AARONSON, Keith D SLAUGHTER, Mark S JEEVANANDAM, Valluvan ANDERSON, Allen S KORMOS, Robert L TEUTEBERG, Jeffrey J LEVY, Wayne C NAFTEL, David C BITTMAN, Richard M PAGANI, Francis D HATHAWAY, David R BOYCE, Steven W MILLER, Leslie W MCGEE, Edwin C COTTS, William G ACKER, Michael A JESSUP, Mariell L GREGORIC, Igor D LOYALKA, Pranav FRAZIER, O. H |
| description | Contemporary ventricular assist device therapy results in a high rate of successful heart transplantation but is associated with bleeding, infections, and other complications. Further reductions in pump size, centrifugal design, and intrapericardial positioning may reduce complications and improve outcomes.
We studied a small, intrapericardially positioned, continuous-flow centrifugal pump in patients requiring an implanted ventricular assist device as a bridge to heart transplantation. The course of investigational pump recipients was compared with that of patients implanted contemporaneously with commercially available devices. The primary outcome, success, was defined as survival on the originally implanted device, transplantation, or explantation for ventricular recovery at 180 days and was evaluated for both noninferiority and superiority. Secondary outcomes included a comparison of survival between groups and functional and quality-of-life outcomes and adverse events in the investigational device group. A total of 140 patients received the investigational pump, and 499 patients received a commercially available pump implanted contemporaneously. Success occurred in 90.7% of investigational pump patients and 90.1% of controls, establishing the noninferiority of the investigational pump (P |
| doi_str_mv | 10.1161/circulationaha.111.058412 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1035101233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1035101233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-6f4dd9a3f471222c66ed5cfb4db853e8d13f20ce6b18ff8a2b7a9e5355ed78893</originalsourceid><addsrcrecordid>eNpFkE9P3DAQxS1UBAvtV6jcQ6UeyNb_4xyjqLArrViEds_RxLHBVTZJ7USo3x6X3cJpNE-_mXnzEPpGyZJSRX8aH8zcweSHHp4haXRJpBaUnaEFlUxkQvLiE1oQQoos54xdoqsYf6dW8VxeoEvGFC2YFgv0vI8WDw5Dj9f9FGC0wRsIrYfuBldDP_l-HuaY3XbDSxJsYrybn6DDD_NhxL7HD8lHkiMuX8An_AmvLIQJ7wL0ceygn96MfkbnDrpov5zqNdrf_tpVq2yzvVtX5SYzQokpU060bQHciZwyxoxStpXGNaJttORWt5Q7RoxVDdXOaWBNDoWVXErb5loX_Br9OO4dw_BntnGqDz4a2yUjNj1SU8IlJZRxntDiiJowxBisq8fgDxD-Jqj-F3RdrR-r_abcrbf35apMGq2PQafZr6czc3Ow7fvk_2QT8P0EQDTQuZSG8fGDU0QpXeT8FZTPiwo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035101233</pqid></control><display><type>article</type><title>Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>AARONSON, Keith D ; SLAUGHTER, Mark S ; JEEVANANDAM, Valluvan ; ANDERSON, Allen S ; KORMOS, Robert L ; TEUTEBERG, Jeffrey J ; LEVY, Wayne C ; NAFTEL, David C ; BITTMAN, Richard M ; PAGANI, Francis D ; HATHAWAY, David R ; BOYCE, Steven W ; MILLER, Leslie W ; MCGEE, Edwin C ; COTTS, William G ; ACKER, Michael A ; JESSUP, Mariell L ; GREGORIC, Igor D ; LOYALKA, Pranav ; FRAZIER, O. H</creator><creatorcontrib>AARONSON, Keith D ; SLAUGHTER, Mark S ; JEEVANANDAM, Valluvan ; ANDERSON, Allen S ; KORMOS, Robert L ; TEUTEBERG, Jeffrey J ; LEVY, Wayne C ; NAFTEL, David C ; BITTMAN, Richard M ; PAGANI, Francis D ; HATHAWAY, David R ; BOYCE, Steven W ; MILLER, Leslie W ; MCGEE, Edwin C ; COTTS, William G ; ACKER, Michael A ; JESSUP, Mariell L ; GREGORIC, Igor D ; LOYALKA, Pranav ; FRAZIER, O. H ; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators</creatorcontrib><description>Contemporary ventricular assist device therapy results in a high rate of successful heart transplantation but is associated with bleeding, infections, and other complications. Further reductions in pump size, centrifugal design, and intrapericardial positioning may reduce complications and improve outcomes.
We studied a small, intrapericardially positioned, continuous-flow centrifugal pump in patients requiring an implanted ventricular assist device as a bridge to heart transplantation. The course of investigational pump recipients was compared with that of patients implanted contemporaneously with commercially available devices. The primary outcome, success, was defined as survival on the originally implanted device, transplantation, or explantation for ventricular recovery at 180 days and was evaluated for both noninferiority and superiority. Secondary outcomes included a comparison of survival between groups and functional and quality-of-life outcomes and adverse events in the investigational device group. A total of 140 patients received the investigational pump, and 499 patients received a commercially available pump implanted contemporaneously. Success occurred in 90.7% of investigational pump patients and 90.1% of controls, establishing the noninferiority of the investigational pump (P<0.001; 15% noninferiority margin). At 6 months, median 6-minute walk distance improved by 128.5 m, and both disease-specific and global quality-of-life scores improved significantly.
A small, intrapericardially positioned, continuous-flow, centrifugal pump was noninferior to contemporaneously implanted, commercially available ventricular assist devices. Functional capacity and quality of life improved markedly, and the adverse event profile was favorable.
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00751972.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/circulationaha.111.058412</identifier><identifier>PMID: 22619284</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular system ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Female ; Follow-Up Studies ; Heart Failure - mortality ; Heart Failure - physiopathology ; Heart Failure - surgery ; Heart Transplantation - mortality ; Heart Transplantation - trends ; Heart-Assist Devices - trends ; Humans ; Male ; Medical sciences ; Middle Aged ; Pericardium - physiopathology ; Pharmacology. Drug treatments ; Prospective Studies ; Surveys and Questionnaires ; Survival Rate - trends ; Treatment Outcome ; Vasodilator agents. Cerebral vasodilators ; Ventricular Dysfunction, Left - mortality ; Ventricular Dysfunction, Left - physiopathology ; Ventricular Dysfunction, Left - surgery ; Waiting Lists - mortality</subject><ispartof>Circulation (New York, N.Y.), 2012-06, Vol.125 (25), p.3191-3200</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-6f4dd9a3f471222c66ed5cfb4db853e8d13f20ce6b18ff8a2b7a9e5355ed78893</citedby><cites>FETCH-LOGICAL-c464t-6f4dd9a3f471222c66ed5cfb4db853e8d13f20ce6b18ff8a2b7a9e5355ed78893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26066897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22619284$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AARONSON, Keith D</creatorcontrib><creatorcontrib>SLAUGHTER, Mark S</creatorcontrib><creatorcontrib>JEEVANANDAM, Valluvan</creatorcontrib><creatorcontrib>ANDERSON, Allen S</creatorcontrib><creatorcontrib>KORMOS, Robert L</creatorcontrib><creatorcontrib>TEUTEBERG, Jeffrey J</creatorcontrib><creatorcontrib>LEVY, Wayne C</creatorcontrib><creatorcontrib>NAFTEL, David C</creatorcontrib><creatorcontrib>BITTMAN, Richard M</creatorcontrib><creatorcontrib>PAGANI, Francis D</creatorcontrib><creatorcontrib>HATHAWAY, David R</creatorcontrib><creatorcontrib>BOYCE, Steven W</creatorcontrib><creatorcontrib>MILLER, Leslie W</creatorcontrib><creatorcontrib>MCGEE, Edwin C</creatorcontrib><creatorcontrib>COTTS, William G</creatorcontrib><creatorcontrib>ACKER, Michael A</creatorcontrib><creatorcontrib>JESSUP, Mariell L</creatorcontrib><creatorcontrib>GREGORIC, Igor D</creatorcontrib><creatorcontrib>LOYALKA, Pranav</creatorcontrib><creatorcontrib>FRAZIER, O. H</creatorcontrib><creatorcontrib>HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators</creatorcontrib><title>Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Contemporary ventricular assist device therapy results in a high rate of successful heart transplantation but is associated with bleeding, infections, and other complications. Further reductions in pump size, centrifugal design, and intrapericardial positioning may reduce complications and improve outcomes.
We studied a small, intrapericardially positioned, continuous-flow centrifugal pump in patients requiring an implanted ventricular assist device as a bridge to heart transplantation. The course of investigational pump recipients was compared with that of patients implanted contemporaneously with commercially available devices. The primary outcome, success, was defined as survival on the originally implanted device, transplantation, or explantation for ventricular recovery at 180 days and was evaluated for both noninferiority and superiority. Secondary outcomes included a comparison of survival between groups and functional and quality-of-life outcomes and adverse events in the investigational device group. A total of 140 patients received the investigational pump, and 499 patients received a commercially available pump implanted contemporaneously. Success occurred in 90.7% of investigational pump patients and 90.1% of controls, establishing the noninferiority of the investigational pump (P<0.001; 15% noninferiority margin). At 6 months, median 6-minute walk distance improved by 128.5 m, and both disease-specific and global quality-of-life scores improved significantly.
A small, intrapericardially positioned, continuous-flow, centrifugal pump was noninferior to contemporaneously implanted, commercially available ventricular assist devices. Functional capacity and quality of life improved markedly, and the adverse event profile was favorable.
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00751972.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Failure - mortality</subject><subject>Heart Failure - physiopathology</subject><subject>Heart Failure - surgery</subject><subject>Heart Transplantation - mortality</subject><subject>Heart Transplantation - trends</subject><subject>Heart-Assist Devices - trends</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pericardium - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Surveys and Questionnaires</subject><subject>Survival Rate - trends</subject><subject>Treatment Outcome</subject><subject>Vasodilator agents. Cerebral vasodilators</subject><subject>Ventricular Dysfunction, Left - mortality</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><subject>Ventricular Dysfunction, Left - surgery</subject><subject>Waiting Lists - mortality</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE9P3DAQxS1UBAvtV6jcQ6UeyNb_4xyjqLArrViEds_RxLHBVTZJ7USo3x6X3cJpNE-_mXnzEPpGyZJSRX8aH8zcweSHHp4haXRJpBaUnaEFlUxkQvLiE1oQQoos54xdoqsYf6dW8VxeoEvGFC2YFgv0vI8WDw5Dj9f9FGC0wRsIrYfuBldDP_l-HuaY3XbDSxJsYrybn6DDD_NhxL7HD8lHkiMuX8An_AmvLIQJ7wL0ceygn96MfkbnDrpov5zqNdrf_tpVq2yzvVtX5SYzQokpU060bQHciZwyxoxStpXGNaJttORWt5Q7RoxVDdXOaWBNDoWVXErb5loX_Br9OO4dw_BntnGqDz4a2yUjNj1SU8IlJZRxntDiiJowxBisq8fgDxD-Jqj-F3RdrR-r_abcrbf35apMGq2PQafZr6czc3Ow7fvk_2QT8P0EQDTQuZSG8fGDU0QpXeT8FZTPiwo</recordid><startdate>20120626</startdate><enddate>20120626</enddate><creator>AARONSON, Keith D</creator><creator>SLAUGHTER, Mark S</creator><creator>JEEVANANDAM, Valluvan</creator><creator>ANDERSON, Allen S</creator><creator>KORMOS, Robert L</creator><creator>TEUTEBERG, Jeffrey J</creator><creator>LEVY, Wayne C</creator><creator>NAFTEL, David C</creator><creator>BITTMAN, Richard M</creator><creator>PAGANI, Francis D</creator><creator>HATHAWAY, David R</creator><creator>BOYCE, Steven W</creator><creator>MILLER, Leslie W</creator><creator>MCGEE, Edwin C</creator><creator>COTTS, William G</creator><creator>ACKER, Michael A</creator><creator>JESSUP, Mariell L</creator><creator>GREGORIC, Igor D</creator><creator>LOYALKA, Pranav</creator><creator>FRAZIER, O. H</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120626</creationdate><title>Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation</title><author>AARONSON, Keith D ; SLAUGHTER, Mark S ; JEEVANANDAM, Valluvan ; ANDERSON, Allen S ; KORMOS, Robert L ; TEUTEBERG, Jeffrey J ; LEVY, Wayne C ; NAFTEL, David C ; BITTMAN, Richard M ; PAGANI, Francis D ; HATHAWAY, David R ; BOYCE, Steven W ; MILLER, Leslie W ; MCGEE, Edwin C ; COTTS, William G ; ACKER, Michael A ; JESSUP, Mariell L ; GREGORIC, Igor D ; LOYALKA, Pranav ; FRAZIER, O. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-6f4dd9a3f471222c66ed5cfb4db853e8d13f20ce6b18ff8a2b7a9e5355ed78893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Failure - mortality</topic><topic>Heart Failure - physiopathology</topic><topic>Heart Failure - surgery</topic><topic>Heart Transplantation - mortality</topic><topic>Heart Transplantation - trends</topic><topic>Heart-Assist Devices - trends</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pericardium - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Surveys and Questionnaires</topic><topic>Survival Rate - trends</topic><topic>Treatment Outcome</topic><topic>Vasodilator agents. Cerebral vasodilators</topic><topic>Ventricular Dysfunction, Left - mortality</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><topic>Ventricular Dysfunction, Left - surgery</topic><topic>Waiting Lists - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AARONSON, Keith D</creatorcontrib><creatorcontrib>SLAUGHTER, Mark S</creatorcontrib><creatorcontrib>JEEVANANDAM, Valluvan</creatorcontrib><creatorcontrib>ANDERSON, Allen S</creatorcontrib><creatorcontrib>KORMOS, Robert L</creatorcontrib><creatorcontrib>TEUTEBERG, Jeffrey J</creatorcontrib><creatorcontrib>LEVY, Wayne C</creatorcontrib><creatorcontrib>NAFTEL, David C</creatorcontrib><creatorcontrib>BITTMAN, Richard M</creatorcontrib><creatorcontrib>PAGANI, Francis D</creatorcontrib><creatorcontrib>HATHAWAY, David R</creatorcontrib><creatorcontrib>BOYCE, Steven W</creatorcontrib><creatorcontrib>MILLER, Leslie W</creatorcontrib><creatorcontrib>MCGEE, Edwin C</creatorcontrib><creatorcontrib>COTTS, William G</creatorcontrib><creatorcontrib>ACKER, Michael A</creatorcontrib><creatorcontrib>JESSUP, Mariell L</creatorcontrib><creatorcontrib>GREGORIC, Igor D</creatorcontrib><creatorcontrib>LOYALKA, Pranav</creatorcontrib><creatorcontrib>FRAZIER, O. H</creatorcontrib><creatorcontrib>HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AARONSON, Keith D</au><au>SLAUGHTER, Mark S</au><au>JEEVANANDAM, Valluvan</au><au>ANDERSON, Allen S</au><au>KORMOS, Robert L</au><au>TEUTEBERG, Jeffrey J</au><au>LEVY, Wayne C</au><au>NAFTEL, David C</au><au>BITTMAN, Richard M</au><au>PAGANI, Francis D</au><au>HATHAWAY, David R</au><au>BOYCE, Steven W</au><au>MILLER, Leslie W</au><au>MCGEE, Edwin C</au><au>COTTS, William G</au><au>ACKER, Michael A</au><au>JESSUP, Mariell L</au><au>GREGORIC, Igor D</au><au>LOYALKA, Pranav</au><au>FRAZIER, O. H</au><aucorp>HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2012-06-26</date><risdate>2012</risdate><volume>125</volume><issue>25</issue><spage>3191</spage><epage>3200</epage><pages>3191-3200</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Contemporary ventricular assist device therapy results in a high rate of successful heart transplantation but is associated with bleeding, infections, and other complications. Further reductions in pump size, centrifugal design, and intrapericardial positioning may reduce complications and improve outcomes.
We studied a small, intrapericardially positioned, continuous-flow centrifugal pump in patients requiring an implanted ventricular assist device as a bridge to heart transplantation. The course of investigational pump recipients was compared with that of patients implanted contemporaneously with commercially available devices. The primary outcome, success, was defined as survival on the originally implanted device, transplantation, or explantation for ventricular recovery at 180 days and was evaluated for both noninferiority and superiority. Secondary outcomes included a comparison of survival between groups and functional and quality-of-life outcomes and adverse events in the investigational device group. A total of 140 patients received the investigational pump, and 499 patients received a commercially available pump implanted contemporaneously. Success occurred in 90.7% of investigational pump patients and 90.1% of controls, establishing the noninferiority of the investigational pump (P<0.001; 15% noninferiority margin). At 6 months, median 6-minute walk distance improved by 128.5 m, and both disease-specific and global quality-of-life scores improved significantly.
A small, intrapericardially positioned, continuous-flow, centrifugal pump was noninferior to contemporaneously implanted, commercially available ventricular assist devices. Functional capacity and quality of life improved markedly, and the adverse event profile was favorable.
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00751972.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>22619284</pmid><doi>10.1161/circulationaha.111.058412</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-7322 |
| ispartof | Circulation (New York, N.Y.), 2012-06, Vol.125 (25), p.3191-3200 |
| issn | 0009-7322 1524-4539 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1035101233 |
| source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
| subjects | Adult Aged Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female Follow-Up Studies Heart Failure - mortality Heart Failure - physiopathology Heart Failure - surgery Heart Transplantation - mortality Heart Transplantation - trends Heart-Assist Devices - trends Humans Male Medical sciences Middle Aged Pericardium - physiopathology Pharmacology. Drug treatments Prospective Studies Surveys and Questionnaires Survival Rate - trends Treatment Outcome Vasodilator agents. Cerebral vasodilators Ventricular Dysfunction, Left - mortality Ventricular Dysfunction, Left - physiopathology Ventricular Dysfunction, Left - surgery Waiting Lists - mortality |
| title | Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A25%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20an%20Intrapericardial,%20Continuous-Flow,%20Centrifugal%20Pump%20in%20Patients%20Awaiting%20Heart%20Transplantation&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=AARONSON,%20Keith%20D&rft.aucorp=HeartWare%20Ventricular%20Assist%20Device%20(HVAD)%20Bridge%20to%20Transplant%20ADVANCE%20Trial%20Investigators&rft.date=2012-06-26&rft.volume=125&rft.issue=25&rft.spage=3191&rft.epage=3200&rft.pages=3191-3200&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/circulationaha.111.058412&rft_dat=%3Cproquest_cross%3E1035101233%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035101233&rft_id=info:pmid/22619284&rfr_iscdi=true |